Home » Stocks » MEDS » Financials

Trxade Group, Inc. (MEDS)

Stock Price: $4.69 USD -0.57 (-10.84%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year20202019201820172016201520142013
Revenue17.127.443.832.932.482.911.500.96
Revenue Growth130.26%94.07%30.72%18.11%-14.79%94.66%56.53%-
Cost of Revenue11.422.570.45--0.190.440.94
Gross Profit5.714.873.382.932.482.721.060.01
Selling, General & Admin7.494.383.472.543.492.862.492.10
Other Operating Expenses0.730.370.00-0.07-0.020.000.000.00
Operating Expenses8.214.753.472.473.472.862.492.10
Operating Income-2.510.13-0.090.46-0.98-0.14-1.43-2.08
Interest Expense / Income0.030.050.060.160.150.120.000.01
Other Expense / Income0.000.36-0.150.021.620.860.580.00
Pretax Income-2.54-0.280.010.29-2.76-1.12-2.01-2.09
Net Income-2.54-0.280.010.29-2.76-1.12-2.01-2.09
Shares Outstanding (Basic)7.715.935.385.335.265.224.972.35
Shares Outstanding (Diluted)7.715.935.835.685.265.224.972.35
Shares Change29.96%10.27%0.95%1.3%0.73%4.98%111.54%-
EPS (Basic)-0.33-0.05-0.06-0.54-0.24-0.42-0.90
EPS (Diluted)-0.33-0.05-0.06-0.54-0.24-0.42-0.90
Free Cash Flow Per Share-0.290.010.050.03-0.100.02-0.21-0.36
Gross Margin33.3%65.5%88.3%100%100%93.5%70.6%1.2%
Operating Margin-14.6%1.7%-2.3%15.8%-39.6%-4.7%-95.7%-218.0%
Profit Margin-14.8%-3.8%0.2%9.9%-111.2%-38.4%-134.5%-218.8%
FCF Margin-13.2%0.8%6.7%5.9%-20.3%3.1%-71.2%-87.2%
EBITDA-2.40-0.140.070.45-2.61-0.99-2.00-2.08
EBITDA Margin-14%-1.8%1.7%15.2%-105.1%-34.1%-133.9%-217.6%
EBIT-2.51-0.230.070.45-2.61-1.00-2.01-2.08
EBIT Margin-14.6%-3.1%1.7%15.2%-105.1%-34.3%-134.2%-218.0%